Tapewire

Nasdaq · USD

ATOS

ATOSSA THERAPEUTICS, INC.

Export transactions ↓
Tapewire entity
7556
SEC CIK
0001488039
Parsed reports
96

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 30, 2018 Filed May 31, 2018 19:24 UTC
Guse KyleCFO, Gen Counsel and Secretary
PurchaseSeries B Convertible Preferred Stock · Derivative 8 $1,000.00 Strike: $3.52 $8,000.00
Disclosure

SEC source: 0001615774-18-004655 · s110545_form4.xml · derivative · entry 1

Guse Kyle · CIK 0001566618 · CFO, Gen Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8

Underlying: Common Stock · 2,273 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of Series B Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $3.52.

F4 · price: Shares of Series B Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series B Convertible Preferred Stock and 284 Warrants.

F2 · derivative.expiration_date: Shares of Series B Convertible Preferred Stock do not expire.

F3 · derivative.underlying_shares: No fractional shares will be issued upon conversion. At its election, the Company will either issue a cash adjustment or round up to the next whole share. The number reflected here assumes rounding up to the next whole share.

Read SEC document
November 15, 2017 Filed Nov 16, 2017 11:03 UTC
Guse KyleCFO, Gen Counsel and Secretary
PurchaseCommon Stock 1,400 $0.34 $471.10
Disclosure

SEC source: 0001615774-17-006777 · s108207_form4.xml · nonDerivative · entry 2

Guse Kyle · CIK 0001566618 · CFO, Gen Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Read SEC document
November 15, 2017 Filed Nov 16, 2017 11:03 UTC
Guse KyleCFO, Gen Counsel and Secretary
PurchaseCommon Stock 8,600 $0.34 $2,898.20
Disclosure

SEC source: 0001615774-17-006777 · s108207_form4.xml · nonDerivative · entry 1

Guse Kyle · CIK 0001566618 · CFO, Gen Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,600

Read SEC document
May 24, 2017 Filed May 26, 2017 13:48 UTC
QUAY STEVEN CDirector · President & CEO
GrantStock Option (right to buy) · Derivative 575,893 $0.00 Strike: $0.47 $0.00
Disclosure

SEC source: 0001615774-17-002743 · s106363_form4.xml · derivative · entry 1

QUAY STEVEN C · CIK 0001008227 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 651,785

Underlying: Common Stock · 575,893 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 48 months.

Read SEC document
May 24, 2017 Filed May 26, 2017 17:53 UTC GrantStock Option (right to buy) · Derivative 49,531 $0.00 Strike: $0.47 $0.00
Disclosure

SEC source: 0001615774-17-002747 · s106365_form4.xml · derivative · entry 1

Steinhart Richard I · CIK 0001293789 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,062

Underlying: Common Stock · 49,531 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months.

Read SEC document
May 24, 2017 Filed May 26, 2017 17:55 UTC GrantStock Option (right to buy) · Derivative 54,949 $0.00 Strike: $0.47 $0.00
Disclosure

SEC source: 0001615774-17-002749 · s106366_form4.xml · derivative · entry 1

WEAVER GREGORY L · CIK 0001251779 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,917

Underlying: Common Stock · 54,949 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months.

Read SEC document
May 24, 2017 Filed May 26, 2017 17:50 UTC GrantStock Option (right to buy) · Derivative 57,685 $0.00 Strike: $0.47 $0.00
Disclosure

SEC source: 0001615774-17-002745 · s106364_form4.xml · derivative · entry 1

Remmel H. Lawrence · CIK 0001551817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,369

Underlying: Common Stock · 57,685 shares

Expires 2027-05-24

F1 · shares: Pursuant to the policies of Pryor Cashman, the law firm of which Mr. Remmel is a partner, the options Mr. Remmel receives for his services as a director are assigned to the firm.

F2 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months.

F1 · derivative.underlying_shares: Pursuant to the policies of Pryor Cashman, the law firm of which Mr. Remmel is a partner, the options Mr. Remmel receives for his services as a director are assigned to the firm.

F1 · balance_after: Pursuant to the policies of Pryor Cashman, the law firm of which Mr. Remmel is a partner, the options Mr. Remmel receives for his services as a director are assigned to the firm.

Read SEC document
May 24, 2017 Filed May 26, 2017 17:46 UTC
Guse KyleCFO, Gen Counsel and Secretary
GrantStock Option (right to buy) · Derivative 495,333 $0.00 Strike: $0.47 $0.00
Disclosure

SEC source: 0001615774-17-002741 · s106362_form4.xml · derivative · entry 1

Guse Kyle · CIK 0001566618 · CFO, Gen Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 640,667

Underlying: Common Stock · 495,333 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 48 months.

Read SEC document
May 24, 2017 Filed May 26, 2017 17:44 UTC GrantStock Option (right to buy) · Derivative 64,132 $0.00 Strike: $0.47 $0.00
Disclosure

SEC source: 0001615774-17-002739 · s106361_form4.xml · derivative · entry 1

Galli Stephen J · CIK 0001551951 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,263

Underlying: Common Stock · 64,132 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months.

Read SEC document
May 24, 2017 Filed May 26, 2017 17:41 UTC GrantStock Option (right to buy) · Derivative 60,202 $0.00 Strike: $0.47 $0.00
Disclosure

SEC source: 0001615774-17-002737 · s106360_form4.xml · derivative · entry 1

Chen Shu-Chih · CIK 0001552127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,404

Underlying: Common Stock · 60,202 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months.

Read SEC document
April 17, 2017 Filed Apr 18, 2017 21:10 UTC PurchaseCommon Stock 2,500 $0.63 $1,580.00
Disclosure

SEC source: 0001615774-17-001757 · s105907_form4.xml · nonDerivative · entry 1

Remmel H. Lawrence · CIK 0001551817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,126

F1 · balance_after: The Reporting Person disclaims beneficial ownership of the 133 shares of common stock held by the Reporting Person's spouse and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F1 · ownership.direct: The Reporting Person disclaims beneficial ownership of the 133 shares of common stock held by the Reporting Person's spouse and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.